C07H1/00

NON-CALORIC SWEETENERS AND METHODS FOR SYNTHESIZING
20230002435 · 2023-01-05 · ·

Disclosed are steviol glycosides referred to as rebaudioside V and rebaudioside W. Also disclosed are methods for producing rebaudioside M (Reb M), rebausoside G (Reb G), rebaudioside KA (Reb KA), rebaudioside V (Reb V) and rebaudioside (Reb W).

DEVICE AND METHOD FOR PRODUCING SUCROSE-6-ESTER

Provided are a device and a method for producing a sucrose-6-ester. The device includes a shell, a film scraping apparatus, and a base, wherein the film scraping apparatus is arranged on the base, and the shell covers the film scraping apparatus and the base; the shell is provided with a reaction solution inlet and a condensated water outlet; the base is provided with a carboxylate feed pipe, a reaction product discharge pipe, and a reaction channel connected to the carboxylate feed pipe; the film scraping apparatus includes a temperature control unit, a rotary tube, and a plurality of scrapers arranged on an inner wall of the rotary tube, and an outer edge of each of the scrapers abuts against an outer wall of the temperature control unit; and the rotary tube is able to rotate around the temperature control unit.

OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE

The present invention relates to an oligonucleotide comprising at least one phosphorodithioate internucleoside linkage of formula (I) (I) as defined in the description and in the claim. The oligonucleotide of the invention can be used as a medicement.

##STR00001##

OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE

The present invention relates to an oligonucleotide comprising at least one phosphorodithioate internucleoside linkage of formula (I) (I) as defined in the description and in the claim. The oligonucleotide of the invention can be used as a medicement.

##STR00001##

COMPOSITION FOR PREPARING ALLULOSE AND METHOD FOR PREPARING ALLULOSE BY USING SAME

Provided are a novel composition for preparing allulose and a method of preparing allulose using the same.

COMPOSITION FOR PREPARING ALLULOSE AND METHOD FOR PREPARING ALLULOSE BY USING SAME

Provided are a novel composition for preparing allulose and a method of preparing allulose using the same.

ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS

Described herein are orally-bioavailable nucleoside analogs and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of coronavirus infections, including SARS-CoV-2 infection.

COMPOSITIONS COMPRISING DICHLOROACETIC ACID, PROCESSES FOR PREPARING SAME AND USES THEREOF

Disclosed is a composition comprising dichloroacetic acid, a process for preparing the same and a use thereof. It has been discovered that the novel impurity is glyoxylic acid, and glyoxylic acid in dichloroacetic acid can be detected and its concentration accurately measured, by ion chromatography method.

Synthesis of O-antigen oligosaccharide compounds of <i>Helicobacter pylori </i>serotype O2
11566040 · 2023-01-31 · ·

Disclosed is synthesis of an O-Antigen oligosaccharide compound of Helicobacter pylori serotype O2, belonging to the field of organic synthesis. The disclosure obtains O-antigen disaccharide to tetracosasaccharide of Helicobacter pylori serotype O.sub.2 by chemical synthesis. A chemical synthesis method which is quite conducive to production of a glucose-α-lglucosidic bond is developed in the disclosure by a protectant strategy, temperature effect, solvent effect, and additive effect. The method is applied in synthesis of an O-antigen oligosaccharide compound of Helicobacter pylori serotype O2 assembled with an amino linking arm. A saccharide conjugate can be prepared from the synthesized O-antigen oligosaccharide compound of Helicobacter pylori serotype O2 assembled with an amino linking arm together with a carrier protein for immunology researches, playing an important role in preventing and treating Helicobacter pylori.

Synthesis of O-antigen oligosaccharide compounds of <i>Helicobacter pylori </i>serotype O2
11566040 · 2023-01-31 · ·

Disclosed is synthesis of an O-Antigen oligosaccharide compound of Helicobacter pylori serotype O2, belonging to the field of organic synthesis. The disclosure obtains O-antigen disaccharide to tetracosasaccharide of Helicobacter pylori serotype O.sub.2 by chemical synthesis. A chemical synthesis method which is quite conducive to production of a glucose-α-lglucosidic bond is developed in the disclosure by a protectant strategy, temperature effect, solvent effect, and additive effect. The method is applied in synthesis of an O-antigen oligosaccharide compound of Helicobacter pylori serotype O2 assembled with an amino linking arm. A saccharide conjugate can be prepared from the synthesized O-antigen oligosaccharide compound of Helicobacter pylori serotype O2 assembled with an amino linking arm together with a carrier protein for immunology researches, playing an important role in preventing and treating Helicobacter pylori.